Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer.
We addressed in this study whether quantifying the extent of disease on bone scans can predict the disease death of patients with advanced prostate cancer using computer-assisted image analysis. Pretreatment radionuclide bone scans were reviewed in 56 patients with bone metastases from prostate cancer, and the percentage of the positive area on a bone scan (%PABS) was quantified automatically using a personal computer with the NIH Image program for estimation of the accurate extent of metastatic bone lesions on a bone scan. The significance of the %PABS as well as the other known prognostic factors was evaluated using univariate and multivariate Cox proportional hazards analysis. In univariate regression analysis, the %PABS (P=0.0155), serum alkaline phosphatase (P=0.0272), the tumour grade based on biopsy (P=0.044) and the number of bone lesions on bone scans (P=0.0388) were well associated with disease-specific survival. In multivariate analysis, the %PABS (P=0.0155, relative risk ratio 2.603), but not the other factors, was the independent predictor of the disease death. These results suggest that the %PABS is a novel parameter for predicting the prognosis of patients with advanced prostatic cancer.
Noguchi
M
M
Department of Urology, Kurume University School of Medicine, Fukuoka, Japan. noguchi@med.kurume-u.ac.jp
Kikuchi
H
H
Ishibashi
M
M
Noda
S
S
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000378:metabolism / Q000401:mortality* / Q000556:secondary; D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000401:mortality* / Q000556:secondary; D006801:Humans; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000401:mortality* / Q000473:pathology; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D014055:Tomography, Emission-Computed
D000469:Alkaline Phosphatase; D017430:Prostate-Specific Antigen